12th January 2022 | Pharma Updates

Curadev joins National Bio Entrepreneurship Competition to encourage Indian Biotech Startups

Curadev Pharma offered one startup a chance to show an investment proposal for USD 50000 to the Curadev Board Members.

CuraTeQ Biologics expands scope of agreement inked with Orion

According to the terms and conditions of the agreement, Orion Corporation will take care of the commercialization of Aurobindo Pharma subsidiary CuraTeQ Biologics’s biosimilar products

Molnupiravir Benefits are More Than the Potential Risks

Around 13 firms in India will manufacture molnupiravir.

Natco Pharma bags Corporate Governance award

Moneylife Foundation Corporate Governance award, started by Sucheta Dalal and Debashis Basu, put Hyderabad-based Natco Pharma on top in the inaugural edition of the award.

Revival of Public Sector Undertaking Pharma sought in Andhra Pradesh

The Praja Arogya Vedika, affiliated with Jan Swasthya Abhiyan, has urged PM Modi to revive pharma units and vaccine plants in the public sector.

DCGI asks States to keep watch on fake tocilizumab injection in India

Use of spurious tocilizumab injections can cause adverse effects in patients.

Bayer's D Narain takes One More Responsibility

D Narain President of Bayer South Asia and Managing Director of Bayer CropScience Ltd. will be also taking charge of smallholder farming for Bayer as a Global Head.